Swiss robotics company Distalmotion has seen its Dexter surgical robot, designed for adult inguinal hernia repair, granted De Novo marketing approval by the US Food and Drug Administration (FDA). The ...

Distalmotion’s Dexter Surgical Robot opens an entirely new era for soft tissue robotics in the outpatient setting and ambulatory surgery centers that will have immediate benefit for patients.

Lausanne, Switzerland, Jan. 10, 2024 (GLOBE NEWSWIRE) -- Distalmotion - a pioneer in surgical robotics, is partnering with Proximie, the leading global health technology platform digitizing operating ...

Distalmotion has grabbed hold of a de novo clearance for its Dexter surgical robot, a system designed for hospitals as well as ambulatory surgery centers. The robotic assistant was cleared by the FDA ...

Lausanne, Switzerland, Aug. 06, 2025 (GLOBE NEWSWIRE) -- Distalmotion today announced continued momentum in its clinical trial plans to support indication expansion of its DEXTER® Robotic Surgery ...

The MarketWatch News Department was not involved in the creation of this content. Lausanne, Switzerland, Nov. 18, 2025 (GLOBE NEWSWIRE) -- Distalmotion, the global MedTech company empowering access to ...

Lausanne, Switzerland, Nov. 18, 2025 (GLOBE NEWSWIRE) -- Distalmotion, the global MedTech company empowering access to the benefits of robotic surgery in outpatient sites of care, today announced the ...

Lausanne, Switzerland, May 28, 2025 (GLOBE NEWSWIRE) -- Distalmotion, the global MedTech company empowering access to the benefits of robotic surgery in more sites of care, today announced that it has ...

Lausanne, Switzerland, Oct. 28, 2024 (GLOBE NEWSWIRE) -- Distalmotion has been granted De Novo approval by the U.S. Food and Drug Administration (FDA) to market the Dexter Surgical Robot for adult ...